Showing results (11-20 of 178) with videos related to
Sort By:
Pageof 18
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|May 4, 2010
Neuroimmunity of HTLV-I InfectionEiji Matsuura, Yoshihisa Yamano, Steven JacobsonMedicine|July 26, 2024
Successful treatment with traditional Japanese medicine (kampo medicine) Yokukansan as a migraine prophylactic drug: A case reportHisanao Akiyama, Yasuhiro Hasegawa, Yoshihisa YamanoNihon Rinsho. Japanese Journal of Clinical Medicine|October 20, 2010
[Development of anti-inflammatory drugs targeted against prostaglandin-related molecules]Tomoo Sato, Toshihiro Nakajima, Yoshihisa YamanoScientific Reports|January 11, 2022
Nationwide cross-sectional survey of patients with relapsing polychondritis in 2019 demonstrates reduction of airway involvement compared with that in 2009Jun Shimizu, Yoshihisa Yamano, Kimito Kawahata, et al.Neurorehabilitation|August 29, 2022
Efficacy of repetitive transcranial magnetic stimulation for gait disturbance in HTLV-1 associated myelopathyNobuyuki Sasaki, Tomoo Sato, Masato Yamatoku, et al.Rinsho Shinkeigaku = Clinical Neurology|February 25, 2021
[A case of nasal discharge resulting in recurrent bacterial meningitis]Naoki Takao, Kenzo Sakurai, Sakae Hino, et al.Medicine|October 19, 2018
Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristicsJun Shimizu, Yoshihisa Yamano, Kimito Kawahata, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 11, 2015
[A survey of HTLV-1 carrier clinics in Japan]Kenji Ishitsuka, Yoshihisa Yamano, Atae Utsunomiya, et al.BMC Rheumatology|September 18, 2020
Elucidation of predictors of disease progression in patients with relapsing polychondritis at the onset: potential impact on patient monitoringJun Shimizu, Yoshihisa Yamano, Kimito Kawahata, et al.Pharmacology & Therapeutics|August 25, 2020
An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) focusing on clinical and laboratory biomarkersJunji Yamauchi, Natsumi Araya, Naoko Yagishita, et al.Pageof 18